REPLAY THERAPEUTICS
Replay Therapeutics develops a hypoimmunogenic iPSC therapeutic platform and redefines gene therapy and genome editing.
REPLAY THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Health Care
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.replay.bio
Status:
Active
Total Funding:
0
Similar Organizations
AddGraft Therapeutics
AddGraft Therapeutics develops gene delivery platform that cures substance abuse disorder through a one-time treatment.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
RegeneMed
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Xcell Therapeutics
Xcell Therapeutics develops and produces serum-free chemically defined media.
Yuanjian Youke
Yuanjian Youke is an integrated CDMO service provider for cell and gene therapy industry.
Current Employees Featured
Founder
Investors List
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Replay Therapeutics
Official Site Inspections
http://www.replay.bio
- Host name: 104.21.16.1
- IP address: 104.21.16.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Replay Therapeutics"
Replay Launches with $55 Million Seed to Reprogram …
Jul 25, 2022 KKR is investing in Replay through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. Ends. About Replay. Replay is a genome writing company, which …See details»
Replay - Crunchbase Company Profile & Funding
Organization. Replay . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Replay is a genome …See details»
Replay - LinkedIn
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay Overview | SignalHire Company Profile
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. ... Organization Website. …See details»
Replay (Drug Discovery) - PitchBook
Jul 7, 2020 Replay (Drug Discovery) General Information Description. Developer of a hypoimmunogenic iPSC therapeutic platform designed for gene therapy and genome engineering. The company offers an assembled toolkit of disruptive …See details»
Replay Company Profile - Office Locations, Competitors, Revenue …
Replay is a company developing an enzyme writing product platform for reprogramming biology by writing and delivering big DNA constructs. It offers genomic products, synthetic gene …See details»
Replay Holdings - Overview, News & Similar companies - ZoomInfo
May 22, 2023 Replay Holdings contact info: Phone number: (858) 859-2610 Website: replay.bio What does Replay Holdings do? Replay is a company that operates in the biotechnology …See details»
Team - Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
Replay Launches with $55 Million Seed to Reprogram Biology by …
Jul 25, 2022 Replay Bio . Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA. KKR and OMX Ventures lead $55 million seed funding round. …See details»
Replay establishes distinguished Scientific Advisory Board
Oct 17, 2022 Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts San Diego, California and London, UK, October...See details»
Replay Bio (company) - Nordic 9
Replay Bio; Replay Bio (private company) replay.bio . See something wrong or missing? Let us know. Offices: London, San Diego. Industry: Biotech Health services. Business model: B2B. …See details»
Replay launches to reprogram biology by writing and delivering …
Jul 25, 2022 Replay’s genomic medicine toolkit comprises several synergistic technology platforms, including synHSV – a high payload capacity HSV vector able to deliver up to 30 …See details»
Replay receives $1.5 million grant for its hypoimmunogenic
Nov 28, 2022 Replay developing uCell™, its universal, off-the-shelf, genomically rewritten, renewable cell source hypoimmunogenic technology, with support from the Bill & Melinda …See details»
Replay Bio news - the latest biotech news from Labiotech.eu
Jul 24, 2023 Replay Bio has announced the launch of Eudora, an HSV (herpes simplex virus) gene therapy company targeting genetic retinal diseases. It is the first of Replay’s product …See details»
Management | Team - Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
The Backyarders were really proud of themselves on Saturday …
21 hours ago Full replay here (or via link in bio): https://youtu. be/GOB_bylhU1Q The Backyarders were really proud of themselves on Saturday night at Pretzelmania VII. Full …See details»
Founders | Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine. All Company FoundersSee details»
U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the
11 hours ago CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the U.S. Food and Drug Administration (FDA) has …See details»
Platform | Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
Renata Martin - Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»